[COVID-19 andcardiovascular diseases].
Identifieur interne : 000022 ( Main/Exploration ); précédent : 000021; suivant : 000023[COVID-19 andcardiovascular diseases].
Auteurs : G. Haeck [Belgique] ; A. Ancion [Belgique] ; P. Marechal [Belgique] ; C. Oury [Belgique] ; P. Lancellotti [Belgique]Source :
- Revue medicale de Liege [ 0370-629X ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Myocarde.
- pathogénicité : Betacoronavirus.
- complications : Comorbidité, Humains, Infections à coronavirus, Maladies cardiovasculaires, Pandémies, Pneumopathie virale, Pronostic.
English descriptors
- KwdEn :
- MESH :
- complications : Cardiovascular Diseases, Coronavirus Infections, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- pathology : Myocardium.
- Comorbidity, Humans, Pandemics, Prognosis.
Abstract
COVID-2019 disease mainly affects the respiratory tract and can progress in severe cases to pneumonia, acute respiratory distress syndrome and multi-organ failure. Patients with prior cardiovascular disease are at higher risk of developing an infection and progressing to a severe form of the disease. Also, due to the growing number of infected cases, it is clear that, in addition to the typical respiratory symptoms caused by the infection, some patients suffer from cardiovascular damage. This condition can, in fact, cause significant myocardial damage, which worsens the disease and affects the prognosis. Based on the results of currently published research, it seems important to discuss the manifestations and characteristics of myocardial damage induced by COVID-19 and its impact on patient prognosis.
Le COVID-19 affecte principalement les voies respiratoires et peut évoluer, dans les cas graves, vers une pneumonie, un syndrome de détresse respiratoire aiguë et une défaillance multi-systémique. Les patients souffrant d’une atteinte cardiovasculaire préalable sont plus à risque de développer une infection et d’évoluer vers une forme grave de la maladie. Aussi, de par le nombre croissant de cas infectés, force est de constater, qu’en plus des symptômes respiratoires typiques causés par l’infection, certains patients souffrent d’atteintes cardiovasculaires. Cette affection peut, en effet, entraîner des dommages myocardiques importants, qui aggravent la maladie et affectent le pronostic. Sur base des résultats des recherches actuellement publiées, il nous semble important de discuter des manifestations et des caractéristiques des atteintes myocardiques induites par le COVID-19 et de son impact sur le pronostic.
PubMed: 32267110
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[COVID-19 andcardiovascular diseases].</title><author><name sortKey="Haeck, G" sort="Haeck, G" uniqKey="Haeck G" first="G" last="Haeck">G. Haeck</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège</wicri:regionArea><wicri:noRegion>CHU Liège</wicri:noRegion></affiliation></author><author><name sortKey="Ancion, A" sort="Ancion, A" uniqKey="Ancion A" first="A" last="Ancion">A. Ancion</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège</wicri:regionArea><wicri:noRegion>CHU Liège</wicri:noRegion></affiliation></author><author><name sortKey="Marechal, P" sort="Marechal, P" uniqKey="Marechal P" first="P" last="Marechal">P. Marechal</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège</wicri:regionArea><wicri:noRegion>CHU Liège</wicri:noRegion></affiliation></author><author><name sortKey="Oury, C" sort="Oury, C" uniqKey="Oury C" first="C" last="Oury">C. Oury</name><affiliation wicri:level="1"><nlm:affiliation>GIGA Cardiovascular Sciences, ULiège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>GIGA Cardiovascular Sciences, ULiège</wicri:regionArea><wicri:noRegion>ULiège</wicri:noRegion></affiliation></author><author><name sortKey="Lancellotti, P" sort="Lancellotti, P" uniqKey="Lancellotti P" first="P" last="Lancellotti">P. Lancellotti</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, GIGA Cardiovascular Sciences, Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège, GIGA Cardiovascular Sciences, Liège</wicri:regionArea><wicri:noRegion>Liège</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32267110</idno><idno type="pmid">32267110</idno><idno type="wicri:Area/Main/Corpus">000376</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000376</idno><idno type="wicri:Area/Main/Curation">000376</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000376</idno><idno type="wicri:Area/Main/Exploration">000376</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[COVID-19 andcardiovascular diseases].</title><author><name sortKey="Haeck, G" sort="Haeck, G" uniqKey="Haeck G" first="G" last="Haeck">G. Haeck</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège</wicri:regionArea><wicri:noRegion>CHU Liège</wicri:noRegion></affiliation></author><author><name sortKey="Ancion, A" sort="Ancion, A" uniqKey="Ancion A" first="A" last="Ancion">A. Ancion</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège</wicri:regionArea><wicri:noRegion>CHU Liège</wicri:noRegion></affiliation></author><author><name sortKey="Marechal, P" sort="Marechal, P" uniqKey="Marechal P" first="P" last="Marechal">P. Marechal</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège</wicri:regionArea><wicri:noRegion>CHU Liège</wicri:noRegion></affiliation></author><author><name sortKey="Oury, C" sort="Oury, C" uniqKey="Oury C" first="C" last="Oury">C. Oury</name><affiliation wicri:level="1"><nlm:affiliation>GIGA Cardiovascular Sciences, ULiège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>GIGA Cardiovascular Sciences, ULiège</wicri:regionArea><wicri:noRegion>ULiège</wicri:noRegion></affiliation></author><author><name sortKey="Lancellotti, P" sort="Lancellotti, P" uniqKey="Lancellotti P" first="P" last="Lancellotti">P. Lancellotti</name><affiliation wicri:level="1"><nlm:affiliation>Service de Cardiologie, CHU Liège, GIGA Cardiovascular Sciences, Liège, Belgique.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Cardiologie, CHU Liège, GIGA Cardiovascular Sciences, Liège</wicri:regionArea><wicri:noRegion>Liège</wicri:noRegion></affiliation></author></analytic><series><title level="j">Revue medicale de Liege</title><idno type="ISSN">0370-629X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (pathogenicity)</term><term>Cardiovascular Diseases (complications)</term><term>Comorbidity (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Humans (MeSH)</term><term>Myocardium (pathology)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Prognosis (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (pathogénicité)</term><term>Comorbidité (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Maladies cardiovasculaires (complications)</term><term>Myocarde (anatomopathologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pronostic (MeSH)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Myocarde</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Cardiovascular Diseases</term><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Myocardium</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Comorbidity</term><term>Humans</term><term>Pandemics</term><term>Prognosis</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Comorbidité</term><term>Humains</term><term>Infections à coronavirus</term><term>Maladies cardiovasculaires</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Pronostic</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">COVID-2019 disease mainly affects the respiratory tract and can progress in severe cases to pneumonia, acute respiratory distress syndrome and multi-organ failure. Patients with prior cardiovascular disease are at higher risk of developing an infection and progressing to a severe form of the disease. Also, due to the growing number of infected cases, it is clear that, in addition to the typical respiratory symptoms caused by the infection, some patients suffer from cardiovascular damage. This condition can, in fact, cause significant myocardial damage, which worsens the disease and affects the prognosis. Based on the results of currently published research, it seems important to discuss the manifestations and characteristics of myocardial damage induced by COVID-19 and its impact on patient prognosis.</div><div type="abstract" xml:lang="fr">Le COVID-19 affecte principalement les voies respiratoires et peut évoluer, dans les cas graves, vers une pneumonie, un syndrome de détresse respiratoire aiguë et une défaillance multi-systémique. Les patients souffrant d’une atteinte cardiovasculaire préalable sont plus à risque de développer une infection et d’évoluer vers une forme grave de la maladie. Aussi, de par le nombre croissant de cas infectés, force est de constater, qu’en plus des symptômes respiratoires typiques causés par l’infection, certains patients souffrent d’atteintes cardiovasculaires. Cette affection peut, en effet, entraîner des dommages myocardiques importants, qui aggravent la maladie et affectent le pronostic. Sur base des résultats des recherches actuellement publiées, il nous semble important de discuter des manifestations et des caractéristiques des atteintes myocardiques induites par le COVID-19 et de son impact sur le pronostic.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32267110</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0370-629X</ISSN><JournalIssue CitedMedium="Print"><Volume>75</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Revue medicale de Liege</Title><ISOAbbreviation>Rev Med Liege</ISOAbbreviation></Journal><ArticleTitle>[COVID-19 andcardiovascular diseases].</ArticleTitle><Pagination><MedlinePgn>226-232</MedlinePgn></Pagination><Abstract><AbstractText>COVID-2019 disease mainly affects the respiratory tract and can progress in severe cases to pneumonia, acute respiratory distress syndrome and multi-organ failure. Patients with prior cardiovascular disease are at higher risk of developing an infection and progressing to a severe form of the disease. Also, due to the growing number of infected cases, it is clear that, in addition to the typical respiratory symptoms caused by the infection, some patients suffer from cardiovascular damage. This condition can, in fact, cause significant myocardial damage, which worsens the disease and affects the prognosis. Based on the results of currently published research, it seems important to discuss the manifestations and characteristics of myocardial damage induced by COVID-19 and its impact on patient prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haeck</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de Cardiologie, CHU Liège, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ancion</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de Cardiologie, CHU Liège, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marechal</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de Cardiologie, CHU Liège, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oury</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>GIGA Cardiovascular Sciences, ULiège, Belgique.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lancellotti</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de Cardiologie, CHU Liège, GIGA Cardiovascular Sciences, Liège, Belgique.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>COVID-19 et maladies cardiovasculaires.</VernacularTitle></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>Rev Med Liege</MedlineTA><NlmUniqueID>0404317</NlmUniqueID><ISSNLinking>0370-629X</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Le COVID-19 affecte principalement les voies respiratoires et peut évoluer, dans les cas graves, vers une pneumonie, un syndrome de détresse respiratoire aiguë et une défaillance multi-systémique. Les patients souffrant d’une atteinte cardiovasculaire préalable sont plus à risque de développer une infection et d’évoluer vers une forme grave de la maladie. Aussi, de par le nombre croissant de cas infectés, force est de constater, qu’en plus des symptômes respiratoires typiques causés par l’infection, certains patients souffrent d’atteintes cardiovasculaires. Cette affection peut, en effet, entraîner des dommages myocardiques importants, qui aggravent la maladie et affectent le pronostic. Sur base des résultats des recherches actuellement publiées, il nous semble important de discuter des manifestations et des caractéristiques des atteintes myocardiques induites par le COVID-19 et de son impact sur le pronostic.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N"> Cardiovascular disease </Keyword><Keyword MajorTopicYN="N"> Myocardial injury</Keyword><Keyword MajorTopicYN="N">2019 </Keyword><Keyword MajorTopicYN="N">COVID</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32267110</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Belgique</li></country></list><tree><country name="Belgique"><noRegion><name sortKey="Haeck, G" sort="Haeck, G" uniqKey="Haeck G" first="G" last="Haeck">G. Haeck</name></noRegion><name sortKey="Ancion, A" sort="Ancion, A" uniqKey="Ancion A" first="A" last="Ancion">A. Ancion</name><name sortKey="Lancellotti, P" sort="Lancellotti, P" uniqKey="Lancellotti P" first="P" last="Lancellotti">P. Lancellotti</name><name sortKey="Marechal, P" sort="Marechal, P" uniqKey="Marechal P" first="P" last="Marechal">P. Marechal</name><name sortKey="Oury, C" sort="Oury, C" uniqKey="Oury C" first="C" last="Oury">C. Oury</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000022 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000022 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32267110
|texte= [COVID-19 andcardiovascular diseases].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32267110" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |